Additionally, miR-92a acts as an onco-miRNA in promoting tumor growth of hepatocellular carcinoma (HCC) via inhibition of F-box and WD repeat domain-containing 7 (FBXW7) [32]. Here, FBXW7 is linked to hepatocellular carcinoma.